The Amyotrophic Lateral Sclerosis Therapeutics Market is seeing riluzole ALS therapeutics segment dominate ALS therapeutics commanding approximately 58-62% market share as riluzole ALS therapeutics represents most effective therapeutics for sporadic ALS treatment improving accuracy by 91%, reducing progression time by 68%, and minimizing complications by 75% creating substantial...